CEACAM5 and pancreatic intraductal papillary-mucinous neoplasm: On the other hand, the diagnostic efficacy of CEA in distinguishing benign and invasive IPMNs of the pancreas was less than satisfactory, and the combination of CEA and CA19-9 did not improve the diagnostic accuracy of these indices [20].